BrainChip (BRN) Q2 2026 earnings summary

Executive summary

• Focused on the rapidly growing Edge AI market, emphasizing ultra-low power inference outside data centers, with strong demand in defense, wearables, IoT, radar, and drones.

• Significant progress in hybrid computing and commercialization, with partnerships like IBM Symphony, ASICLAND, Neuromorphyx, Orama.AOI, and MicroIP, and strong traction for AKD1500 and AKD2500 chips.

• Multi-year partnership initiated with Parsons and notable deployments with Raytheon, expanding defense and industrial AI applications.

• Strategy centers on offering both silicon chips and IP, enabling flexibility for large and small customers, with new revenue streams from chip deliveries and developer modules.

• Ended the quarter with a cash balance of $20.3M, down from $25.3M in the prior quarter.

Financial highlights

• AKD1500 chip sales initiated, with approximately 25% of inventory sold, generating regular low-volume sales from Akida Tag, M.2, PCIe, and RPI 5 boards.

• Net operating cash outflows were $4.7M, an improvement from $5.3M in the prior quarter.

• Receipts from customers were $0.15M, down from $0.7M in the previous quarter.

• Payments to suppliers and employees totaled $5.1M, lower than the prior quarter's $6.1M.

• Estimated quarters of funding available: 4.43.

Outlook and guidance

• Roadmap remains on schedule, with expansion of IP offerings, new product launches, and customer evaluations expected in the next six months.

• No fixed financial targets provided due to business unpredictability, but focus remains on execution and increasing bookings.

• Confident in achieving cash flow neutrality, with ongoing evaluation of funding options as needed.

• AKD2500 project remains on schedule for early December tapeout.

• Internal demonstrations of the Generative AI platform expected in late Q3 2026.